• Heighpubs Logo

ISSN: 2640-284X

Editorial

Indian spices and Caffeine treatment for Obesity and Cardiovascular disease

Ian James Martins1-3*

1Centre of Excellence in Alzheimer’s Disease Research and Care, Sarich Neuroscience Research Institute, Edith Cowan University, Verdun Street, Nedlands, 6009, Western Australia, Australia
2School of Psychiatry and Clinical Neurosciences, the University of Western Australia, Nedlands, 6009, Australia
3McCusker Alzheimer’s Research Foundation, Hollywood Medical Centre, 85 Monash Avenue, Suite 22, Nedlands, 6009, Australia

*Address for Correspondence: Dr. Ian James Martins, School of Medical Sciences, Edith Cowan University, Western Australia 6009, Australia, Tel: +61863042574; Email: i.martins@ecu.edu.au

Dates: Submitted: 24 January 2018; Approved: 30 January 2018; Published: 31 January 2018

How to cite this article: Martins IJ. Indian spices and Caffeine treatment for Obesity and Cardiovascular disease. Ann Clin Endocrinol Metabol. 2018; 2: 010-014. DOI: 10.29328/journal.acem.1001005

Copyright License: © 2018 Martins IJ. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords: Neuroendocrine system; Metabolism; Adipose tissue; Liver; Mitphagy; NAFLD; Obesity; Apelin; Sirtuin 1; Nitric oxide; Autoimmune disease; Caffeine; Cardiovascular disease; Curcumin; Cinnamon

Editorial

The global obesity epidemic that was previously reported [1,2] is now to worsen with obesity to double in 73 countries around the world [3,4]. Improving the health of obese individuals by dietary restriction, anti-obese foods and increased physical activity [1] has not reduced the global obesity epidemic. Obesity is linked to nonalcoholic fatty liver disease (NAFLD) [5,6] with complications relevant to the metabolic syndrome and cardiovascular disease [7]. Appetite control has become critical to endocrinology and metabolism with the apelinergic pathway and nuclear receptor Sirtuin 1 (Sirt 1) now connected to the endocrine system [8] and critical to metabolism. The apelin-Sirt 1 interaction involves nitric oxide (NO) [9] that is now considered as the defect [10] in the interaction between the peptide apelin and calorie sensitive gene Sirt 1 involved in NO imbalances in the adipose tissue, liver and the brain.

A model proposed involves the central co-ordination of the neuroendocrine system by the suprachiasmatic system in the hypothalamus with the adipose tissue and liver in the periphery [8]. The apelinergic pathway is linked to NO balance between the brain, adipose tissue and liver [10] with dietary composition (low calorie diets) and reduction of stress [8] essential to maintain the NO co-ordination of the neuroendocrine system between the brain and peripheral tissues. Nutrigenomic diets are now essential to activate Sirt 1 [11] involved in NO regulation that activates the adipose tissue-liver interaction for the prevention of NAFLD. The crosstalk between the adipose tissue and liver has become of major concern in various communities with adipocyte dysfunction linked to the acceleration of NAFLD [12]. Drugs that lower fat absorption and activate adipose tissue and liver Sirt 1 have been recommended for human use [13] but the use of other anti-obese drugs have raised concerns [14].

The composition of diets have now become important with adipogenesis a major disorder connected to NAFLD. The reports of obesity to become a pandemic is now related to accelerated aging with mitophagy [15] the major defect in NAFLD. The adipocyte and its transformation with relevance to apelin-Sirt 1 defects is related to autoimmune disease and linked to mitophagy and NAFLD [9,15-17].

Sirt 1 via peroxisome proliferator-activated receptor gamma coactivator 1-alpha releases apelin [18] with Sirt 1/ peroxisome proliferator-activated receptor gamma coactivator 1-alpha linked to mitochondrial biogenesis [11]. Sirt 1 mutations have been reported in obesity, diabetes, cardiovascular disease and autoimmune disease [2,19-21]. Sirt 1 is the heat shock gene [22,23] with its repression involved with dysregulation of heat shock protein 70 (HSP70), natural killer cell activation and mitophagy [24]. Defective adipose tissue-liver interaction has been treated with caffeine to prevent mitophagy [25,26] linked to adipocyte dysfunction and reversal of NAFLD [27]. Nutrition therapy that allows co-ordination between the brain, adipose tissue and liver activates the apelinergic-Sirt 1 interaction essential for hepatic caffeine metabolism and caffeine’s critical role as modulation of Sirt 1 in the brain [28] important to the prevention of obesity.

The health promoting benefits and protective role of Indian spices [29] have been reported in obesity and NAFLD with their role as an antioxidant and antimicrobial agent important to the maintenance of the adipose tissue-liver interaction. Identification of spices such as five commonly used dietary spices include saffron, curcumin, pepper family, zingiber and cinnamon to inhibit amyloid beta aggregation. The curry spice curcumin has been extensively studied in animal models to reduce amyloid pathology with beneficial effects on the prevention of neurodegeneration in man. Curcumin (Figure 1) has been used in various studies to inhibit adipogenesis and decrease adipose tissue mass [30-33]. In the liver curcumin has been shown to stabilize or reverse NAFLD [34-36] but in specific controls curcumin has been shown to increase liver enzymes in short term studies. Indian spices now as novel therapeutic agents are potent in scavenging of NO [37] with relevance to apelin-Sirt 1 neuroendocrine regulation of NO balance. Curcumin has potent effects on NO synthase [38,39] with regulation of Sirt 1 control of NO synthase in endothelial cell in the liver and heart [8] (Figure 1). Curcumin is a potent inducer of the heat shock response [40,41] with complete interference of the heat shock gene Sirt 1 regulation of HSP 70. Low dose curcumin ingestion is indicated with other Indian spice consumption and their clearance from the body is poorly understood [29] with higher dose curcumin involved with increased HSPs associated with amyloid beta aggregation (Figure 1) induced toxicity [40-42].

Figure 1: Appetite control is critical to endocrinology and metabolism with apelin-Sirt 1 interaction connected to the adipose-tissue interaction. Endocrine therapeutics that involve the apelin-Sirt 1 interaction and mitochondrial biogenesis are essential to reverse adipocyte dysfunction and the induction of NAFLD. Caffeine and Indian spices are involved with reversal of adipocyte dysfunction and NAFLD. Curcumin at hisgher doses should be carefully controlled to avoid NO imbalance connected to elevate HSPs with induction of autoimmune and chronic diseases.

Cinnamon has now been reported to activate the adipose tissue-liver interaction with cinnamon effects on increased adipocyte lipid and glucose metabolism [43-45]. In the liver cinnamon has been used to stabilize NAFLD [46-48] with its important role as a Sirt 1 activator [29] connected to insulin therapy [49] and its maintenance of the adipose-tissue liver interaction. Consumption of spice intake and its quantification (mg/day) in man [29] vary considerably between countries with cinnamon Sirt 1 activation related to curcumin content with higher doses of curcumin relevant as a Sirt 1 inhibitor. Consumption of Indian spices need to be carefully controlled to avoid induction of obesity by complete nullification of caffeine’s co-ordination of the neuroendocrine system by dysregulation of the brain, adipose tissue and liver interaction. Caffeine and its metabolism is critical to cardiovascular disease [50-52] with Indian spice intake (mg/day) now important with relevance to interference with caffeine’s therapeutic properties in man and various species. Delayed caffeine clearance leads to interference with caffeine’s beneficial effect on adipogenesis with increased transport to the brain relevant to mitochondrial induced apoptosis and the induction of Type 3 diabetes [26-28].

Conclusion

The global obesity epidemic that now affects many countries in the world has not improved in spite of dietary restriction, anti-obese foods and increased physical activity. The neuroendocrine system in many obese individuals is defective with an adipose tissue-liver defect that induces NAFLD and cardiovascular disease. Appetite control to reverse NAFLD and obesity has not been successful with revision of dietary composition that may allow activation of the adipose tissue-liver interaction. Indian spices are important to the adipose-tissue interaction but Indian spice intake should be carefully controlled to avoid curcumin toxicity (apelin-Sirt 1 inhibition) associated with defective fat and caffeine metabolism and associated with the induction of autoimmune and neuroendocrine disease.

Acknowledgements

This work was supported by grants from Edith Cowan University, the McCusker Alzheimer’s Research Foundation and the National Health and Medical Research Council.

References

  1. MartinsIJ. Appetite dysregulation and obesity inWestern Countries. LAP LAMBERT Academic Publishing. 2013. Ref.: https://goo.gl/9Q9tnW
  2. Martins IJ. Induction ofNAFLD with Increased Risk of Obesity and Chronic Diseases in DevelopedCountries. OJEM Diseases. 2014; 4: 90-110. Ref.: https://goo.gl/uHz7H6
  3. An R, Ji M, Zhang S. Global warming and obesity: a systematicreview. Obes Rev. 2018; 19: 150-163. Ref.: https://goo.gl/i9GpEv
  4. Friedrich MJ. Global Obesity Epidemic Worsening. JAMA.2017; 318:603. Ref.: https://goo.gl/79iEGw
  5. Fabbrini E, Sullivan S,Klein S. Obesity and non-alcoholicfatty liver disease: biochemical, metabolic, and clinical implications. Hepatology.2010; 51: 679-689. Ref.: https://goo.gl/ebJjFZ
  6. DietrichP, Hellerbrand C. Non-alcoholic fatty liver disease, obesity and themetabolic syndrome. Best Pract Res Clin Gastroenterol. 2014; 28: 637-653.Ref.: https://goo.gl/ecCzVn
  7. Kim SH, Després JP, Koh KK. Obesity and cardiovascular disease:friend or foe? Eur Heart J. 2016; 37: 3560-3568. Ref.: https://goo.gl/4ZjohT
  8. Martins IJ. Nutritionaldiets accelerate amyloid beta metabolism and prevent the induction ofchronic diseases and Alzheimer’s disease. J Endocrinol andMetab. Photon. 2015; 1-48.
  9. Martins IJ. Apelin andSirtuin 1 dysregulation induce Endocrine and Metabolic Disorders inChronic disease. GJEM. 2017; 1:1. Ref.: https://goo.gl/Z3TmLM
  10. MartinsIJ. Apelinergic System Defects with Relevance to Mental Disorders inDiabetes. World J Psychiatry Ment Health Res. 2017; 1: 1001. Ref.: https://goo.gl/q3yoRr
  11. Martins IJ. UnhealthyNutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities. JMol Genet Med. 2015; 9: 1-8. Ref.: https://goo.gl/mWnRMX
  12. QureshiK, Abrams GA. Metabolic liver disease of obesity and role of adiposetissue in the pathogenesis of nonalcoholic fatty liver disease. World JGastroenterol. 2007; 13: 3540-3553. Ref.: https://goo.gl/56N5AG
  13. Martins IJ. Avasimibe andSirt 1 Activators Reverse NAFLD and Obesity. Nov Appro Drug Des Dev. 2017;1: 1-2.
  14. AdanRA. Mechanisms underlying current and future anti-obesity drugs. TrendsNeurosci. 2013; 36: 133-40. Ref.: https://goo.gl/1n2Ha4
  15. García-RuizC, Baulies A, Mari M, García-Rovés PM, Fernandez-Checa JC. Mitochondrialdysfunction in non-alcoholic fatty liver disease and insulin resistance:cause or consequence?Free Radic Res. 2013; 47: 854-868.Ref.: https://goo.gl/iwfFy7
  16. Martins IJ. Defective Inter­playbetween Adipose Tissue and Immune System Induces Non Alcoholic Fatty LiverDisease. Updates Nutr Disorders Ther. 2017; 1: 3.1. Ref.: https://goo.gl/YQSnyd
  17. Martins IJ. Autoimmunedisease and mitochondrial dysfunction in chronic diseases.Res Chron Dis.2017; 1: 10-12. Ref.: https://goo.gl/LXak5D
  18. MazzucotelliA, Ribet C, Castan-Laurell I, Daviaud D, Guigné C, et al. Thetranscriptional co-activator PGC-1alpha up regulates apelin in human andmouse adipocytes. Regul Pept. 2008; 150: 33-37. Ref.: https://goo.gl/rJtdLa
  19. KilicU, Gok O, Bacaksiz A, Izmirli M, Elibol-Can B, et al. SIRT1gene polymorphisms affect the protein expression in cardiovasculardiseases. PLoS One. 2014; 9: 90428. Ref.: https://goo.gl/3Y8B9Y
  20. Biason-Lauber A, Böni-Schnetzler M, HubbardBP, Bouzakri K, Brunner A, etal. Identification of a SIRT1Mutation in a Family with Type 1 Diabetes. Cell Metab. 2013; 17: 448-455.Ref.: https://goo.gl/xjz2Qm
  21. Hughes JW, Herold KC. Novel SIRT1 MutationLinked to Autoimmune Diabetes in Humans. Cell Metab. 2013; 17: 311-312. Ref.: https://goo.gl/NQ5rtv
  22. MartinsIJ. Type 3 diabetes with links to NAFLD and Other Chronic Diseases in theWestern World. Int J Diab and Metab Disord. 2016; 1: 1-5. Ref.: https://goo.gl/hGqXFe
  23. Martins IJ. Heat shock gene Sirtuin 1 regulatespost-prandial lipid metabolism with relevance to nutrition and appetiteregulation in diabetes. Int J Diab Clin Diagn. 2016; 3: 1-3. Ref.: https://goo.gl/WdzCgC
  24. Martins IJ. Regulation ofCore Body Temperature and the Immune System Determines Species Longevity.Curr Updates Gerontol. 2017; 1: 6. Ref.: https://goo.gl/y3tCqE
  25. Martins IJ. CaffeineConsumption and Induction of Obesity in the Developed World. Ann ObesDisord. 2017; 2: 1018. https://goo.gl/km1Unh
  26. Martins IJ. NutritionTherapy Regulates Caffeine Metabolism with Relevance to NAFLD andInduction of Type 3 Diabetes. J Diabetes Metab Disord. 2017; 4: 019. Ref.: https://goo.gl/ukJA55
  27. MartinsIJ. Caffeine with Links to NAFLDand Accelerated Brain Aging. In Tech Open. 2017. Ref.: https://goo.gl/8dZsGD
  28. Martins IJ. Caffeineconsumption with Relevance to Type 3 diabetes and accelerated brain aging.Res Reveiws: Neurosci. 2016; 1: 1-5. Ref.: https://goo.gl/qbUzY8
  29. Martins IJ. Indian Spicesand Unhealthy Diets interfere with Drug Therapy in Diabetes andNeurodegenerative Diseases. Nov Appro Drug Des Dev. 2018; 3: 1-4. Ref.: https://goo.gl/H5YZN4
  30. EjazA, Wu D, Kwan P, Meydani M. Curcumin inhibits adipogenesis in 3T3-L1adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr. 2009; 139:919-925. Ref.: https://goo.gl/XspCuq
  31. TeichT, Pivovarov JA, Porras DP, Dunford EC, Riddell MC. Curcumin limits weightgain, adipose tissue growth, and glucose intolerance following thecessation of exercise and caloric restriction in rats. J Appl Physiol(1985). 2017; 123: 1625-1634. Ref.: https://goo.gl/djjGKY
  32. WangS, Wang X, Ye Z, Xu C, Zhang M, et al. Curcumin promotes browning of whiteadipose tissue in a norepinephrine-dependent way. Biochem Biophys ResCommun. 2015; 466: 247-253. Ref.: https://goo.gl/SuiirT
  33. BradfordPG. Curcumin and obesity.Biofactors. 2013; 39: 78-87. Ref.: https://goo.gl/wkqhdv
  34. InzaugaratME, De Matteo E, Baz P, Lucero D, García CC, et al. New evidence for thetherapeutic potential of curcumin to treat nonalcoholic fatty liverdisease in humans. PLoS ONE. 2017; 12: e0172900. Ref.: https://goo.gl/C5CdXU
  35. PanahiY, Kianpour P, Mohtashami R, Jafari R, Simental-Mendía LE, et al. Efficacyand Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: ARandomized Controlled Trial. Drug Res (Stuttg). 2017; 67: 244-251. Ref.: https://goo.gl/QzbkiS
  36. RahmaniS, Asgary S, Askari G, Keshvari M, Hatamipour M, et al.Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A RandomizedPlacebo-controlled Trial. Phytother Res. 2016; 30: 1540-1548. Ref.: https://goo.gl/oBQ7j7
  37. BaligaMS, Jagetia GC, Rao SK, Babu K. Evaluation of nitric oxide scavengingactivity of certain spices in vitro: a preliminary study. Nahrung. 2003; 47:261-264. Ref.: https://goo.gl/97anfL
  38. KalaivaniP, Saranya RB, Ramakrishnan G, Ranju V, Sathiya S, et al. Cuminum cyminum,a dietary spice, attenuates hypertension via endothelial nitric oxidesynthase and NO pathway in renovascular hypertensive rats. Clin ExpHypertens. 2013; 35: 534-542. Ref.: https://goo.gl/R5V2P9
  39. Nakatake R, Hishikawa H,Matsuhima H, Nakamura Y, Ishizaki M, et al. Curcumin protects liverinflammation by suppressing expression of inducible nitric oxide synthasein primary cultured rat hepatocytes. Functional Foods in Health andDisease. 2017; 7: 716-734. Ref.: https://goo.gl/CyxUaA
  40. CalabreseV, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, et al. Redoxregulation of heat shock protein expression in aging and neurodegenerativedisorders associated with oxidative stress: a nutritional approach. AminoAcids. 2003; 25: 437-444. Ref.: https://goo.gl/kZ3LvS
  41. MaitP, Manna J. Activation of Heat Shock Proteins by Nanocurcumin to PreventNeurodegenerative Diseases. Brain Disord Ther. 2014; 3:139. Ref.: https://goo.gl/vSsgkU
  42. Martins IJ. CalorieSensitive Anti-Aging Gene Regulates Hepatic Amyloid Beta Clearance inDiabetes and Neurodegenerative Diseases. EC Nutrition ECO. 2017; 01: 30-32.Ref.: https://goo.gl/FswPeB
  43. ShatwanIA, Ahmed LA, Badkook MM. Effect of barley flour, crude cinnamon, andtheir combination on glycemia, dyslipidemia, and adipose tissue hormonesin type 2 diabetic rats. J Med Food. 2013; 16: 656-662. Ref.: https://goo.gl/uvZt6j
  44. LopesBP, Gaique TG, Souza LL, Paula GS, Kluck GE, et al. Cinnamon extractimproves the body composition and attenuates lipogenic processes in theliver and adipose tissue of rats. Food Funct. 2015; 6: 3257-3265. Ref.: https://goo.gl/5bCMBm
  45. Kwan HY, Wu J, Su T, ChaoX-C, Liu B, et al. Cinnamon induces browning in subcutaneous adipocytes.Scientific Reports. 2017; 7: 2447. Ref.: https://goo.gl/NGzgYy
  46. AskariF, Rashidkhani B, Hekmatdoost A. Cinnamon may have therapeutic benefits onlipid profile, liver enzymes, insulin resistance, and high-sensitivityC-reactive protein in nonalcoholic fatty liver disease patients. Nutr Res.2014; 34: 143-148. Ref.: https://goo.gl/hCkdx7
  47. Hekmatdoost A. Prevention of Nonalcoholic FattyLiver Disease (NAFLD) Progression to Nonalcoholic Steatohepatitis (NASH)by Modification of Lifestyle and Dietary Supplements. J Clin Nutr Diet.2016; 2: 2. Ref.: https://goo.gl/rRi7VN
  48. EslamparastT, Eghtesad S, Poustchi H, Hekmatdoost A. Recent advances in dietarysupplementation, in treating non-alcoholic fatty liver disease. World J Hepatol. 2015; 7:204-212. Ref.: https://goo.gl/C6dmCa
  49. Martins IJ. Insulin TherapyInactivation is connected to NAFLD and Diabetes Severity Index. J DiabClin Stud. 2017; 1: 001-003. Ref.: https://goo.gl/zXAMW3
  50. WilsonPW, Bloom HL. Caffeine Consumption and Cardiovascular Risks: Little Causefor Concern. J Am Heart Assoc. 2016; 5: 003089. Ref.: Ref.: https://goo.gl/mQymj7
  51. DingM, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffeeconsumption and risk of cardiovascular disease: a systematic review and adose-response meta-analysis of prospective cohort studies. Circulation.2014; 129: 643-659. Ref.: https://goo.gl/eY1FgP
  52. Martins IJ. Genomic Medicine and Acute Cardiovascular Disease Progression. Res Chron Dis. 2018.

Articles

We publish a wide range of article types in the Clinical, Medical, Biology, Engineering, Chemistry and Pharma.

Submit a Manuscript

See guidelines and policies.

Ensuring authors' satisfaction with

  • Friendly and hassle-free publication process
  • Less production time of articles
  • Constructive peer-review
  • Enhancing journal reputation
  • Regular feedback system
  • Quick response to authors' queries
Readmore